154 related articles for article (PubMed ID: 23507037)
21. Benznidazole/Itraconazole Combination Treatment Enhances Anti-Trypanosoma cruzi Activity in Experimental Chagas Disease.
Assíria Fontes Martins T; de Figueiredo Diniz L; Mazzeti AL; da Silva do Nascimento ÁF; Caldas S; Caldas IS; de Andrade IM; Ribeiro I; Bahia MT
PLoS One; 2015; 10(6):e0128707. PubMed ID: 26076455
[TBL] [Abstract][Full Text] [Related]
22. Benznidazole treatment in chronic children infected with Trypanosoma cruzi: serological and molecular follow-up of patients and identification of Discrete Typing Units.
Rumi MM; Pérez Brandán C; Gil JF; D'Amato AM; Ragone PG; Lauthier JJ; Tomasini N; Cimino RO; Orellana V; Lacunza CD; Nasser JR; Basombrío MA; Diosque P
Acta Trop; 2013 Oct; 128(1):130-6. PubMed ID: 23880286
[TBL] [Abstract][Full Text] [Related]
23. Antibody drop in newborns congenitally infected by Trypanosoma cruzi treated with benznidazole.
Chippaux JP; Clavijo AN; Santalla JA; Postigo JR; Schneider D; Brutus L
Trop Med Int Health; 2010 Jan; 15(1):87-93. PubMed ID: 19968839
[TBL] [Abstract][Full Text] [Related]
24. Success of benznidazole chemotherapy in chronic Trypanosoma cruzi-infected patients with a sustained negative PCR result.
Murcia L; Carrilero B; Ferrer F; Roig M; Franco F; Segovia M
Eur J Clin Microbiol Infect Dis; 2016 Nov; 35(11):1819-1827. PubMed ID: 27488437
[TBL] [Abstract][Full Text] [Related]
25. Biological behavior of different Trypanosoma cruzi isolates circulating in an endemic area for Chagas disease in the Gran Chaco region of Argentina.
Ragone PG; Pérez Brandán C; Padilla AM; Monje Rumi M; Lauthier JJ; Alberti D'Amato AM; Tomasini N; Cimino RO; Romero NM; Portelli M; Nasser JR; Basombrío MA; Diosque P
Acta Trop; 2012 Sep; 123(3):196-201. PubMed ID: 22643298
[TBL] [Abstract][Full Text] [Related]
26. Combination therapy with benznidazole and doxycycline shows no additive effect to monotherapy with benznidazole in mice infected with the VL-10 strain of the Trypanosoma cruzi.
Carneiro ACA; Costa GP; Ferreira CS; Ramos IPR; Sarandy MM; Leite ALJ; Menezes APJ; Silva BM; Nogueira KOPC; Carvalho ACC; Gonçalves RV; Talvani A
Int J Cardiol; 2020 Jan; 299():243-248. PubMed ID: 31353153
[TBL] [Abstract][Full Text] [Related]
27. Short report: benznidazole efficacy among Trypanosoma cruzi-infected adolescents after a six-year follow-up.
Andrade AL; Martelli CM; Oliveira RM; Silva SA; Aires AI; Soussumi LM; Covas DT; Silva LS; Andrade JG; Travassos LR; Almeida IC
Am J Trop Med Hyg; 2004 Nov; 71(5):594-7. PubMed ID: 15569790
[TBL] [Abstract][Full Text] [Related]
28. Thioridazine treatment prevents cardiopathy in Trypanosoma cruzi infected mice.
Lo Presti MS; Rivarola HW; Bustamante JM; Fernández AR; Enders JE; Fretes R; Gea S; Paglini-Oliva PA
Int J Antimicrob Agents; 2004 Jun; 23(6):634-6. PubMed ID: 15194137
[TBL] [Abstract][Full Text] [Related]
29. Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection.
de Andrade AL; Zicker F; de Oliveira RM; Almeida Silva S; Luquetti A; Travassos LR; Almeida IC; de Andrade SS; de Andrade JG; Martelli CM
Lancet; 1996 Nov; 348(9039):1407-13. PubMed ID: 8937280
[TBL] [Abstract][Full Text] [Related]
30. DNA damage and nitric oxide synthesis in experimentally infected Balb/c mice with Trypanosoma cruzi.
Ribeiro DA; Calvi SA; Picka MM; Persi E; de Carvalho TB; Caetano PK; Nagoshi LR; Lima CR; Machado JM; Salvadori DM
Exp Parasitol; 2007 Jul; 116(3):296-301. PubMed ID: 17286971
[TBL] [Abstract][Full Text] [Related]
31. Synergic Effect of Allopurinol in Combination with Nitroheterocyclic Compounds against Trypanosoma cruzi.
Mazzeti AL; Diniz LF; Gonçalves KR; WonDollinger RS; Assíria T; Ribeiro I; Bahia MT
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962342
[TBL] [Abstract][Full Text] [Related]
32. Clomipramine and benznidazole association for the treatment of acute experimental Trypanosoma cruzi infection.
Strauss M; Lo Presti MS; Bazán PC; Baez A; Fauro R; Esteves B; Sanchez Negrete O; Cremonezzi D; Paglini-Oliva PA; Rivarola HW
Parasitol Int; 2013 Jun; 62(3):293-9. PubMed ID: 23500720
[TBL] [Abstract][Full Text] [Related]
33. [The chemotherapy of Chagas disease].
Stoppani AO
Medicina (B Aires); 1999; 59 Suppl 2():147-65. PubMed ID: 10668258
[TBL] [Abstract][Full Text] [Related]
34. Effects of canthin-6-one alkaloids from Zanthoxylum chiloperone on Trypanosoma cruzi-infected mice.
Ferreira ME; Nakayama H; de Arias AR; Schinini A; de Bilbao NV; Serna E; Lagoutte D; Soriano-Agatón F; Poupon E; Hocquemiller R; Fournet A
J Ethnopharmacol; 2007 Jan; 109(2):258-63. PubMed ID: 16949231
[TBL] [Abstract][Full Text] [Related]
35. Trypanosoma cruzi: alteration in the lymphoid compartments following interruption of infection by early acute benznidazole therapy in mice.
Olivieri BP; de Souza AP; Cotta-de-Almeida V; de Castro SL; Araújo-Jorge T
Exp Parasitol; 2006 Nov; 114(3):228-34. PubMed ID: 16620811
[TBL] [Abstract][Full Text] [Related]
36. In vivo susceptibility to benznidazole of Trypanosoma cruzi strains from the western Brazilian Amazon.
Teston AP; Monteiro WM; Reis D; Bossolani GD; Gomes ML; de Araújo SM; Bahia MT; Barbosa MG; Toledo MJ
Trop Med Int Health; 2013 Jan; 18(1):85-95. PubMed ID: 23130989
[TBL] [Abstract][Full Text] [Related]
37. Association of clomipramine and allopurinol for the treatment of the experimental infection with Trypanosoma cruzi.
Gobbi P; Baez A; Lo Presti MS; Fernández AR; Enders JE; Fretes R; Gea S; Paglini-Oliva PA; Rivarola HW
Parasitol Res; 2010 Oct; 107(5):1279-83. PubMed ID: 20680335
[TBL] [Abstract][Full Text] [Related]
38. Cardiomyopathy prognosis after benznidazole treatment in chronic canine Chagas' disease.
Santos FM; Lima WG; Gravel AS; Martins TA; Talvani A; Torres RM; Bahia MT
J Antimicrob Chemother; 2012 Aug; 67(8):1987-95. PubMed ID: 22570424
[TBL] [Abstract][Full Text] [Related]
39. Trypanosoma cruzi: effect of benznidazole therapy combined with the iron chelator desferrioxamine in infected mice.
Francisco AF; de Abreu Vieira PM; Arantes JM; Pedrosa ML; Martins HR; Silva M; Veloso VM; de Lana M; Bahia MT; Tafuri WL; Carneiro CM
Exp Parasitol; 2008 Dec; 120(4):314-9. PubMed ID: 18789321
[TBL] [Abstract][Full Text] [Related]
40. Use of an enzyme-linked immunosorbent assay that utilizes the Tc13Tul antigen of Trypanosoma cruzi to monitor patients after treatment with benznidazole.
Santamaría AL; De Rissio AM; Riarte A; Garavaglia PA; Bruballa AC; Rodríguez MA; Irazu LE; Ruiz AM; García GA
Diagn Microbiol Infect Dis; 2013 Jun; 76(2):197-205. PubMed ID: 23537784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
